Medicale CORP 10-Q quarterly reports

Medicale Corp. reported a reduced net loss for Q1 2026, but faces significant going concern doubts and ineffective internal controls as it remains pre-operational.

Medicale Corp. reports continued losses and zero revenue for Q3 2025, raising substantial doubt about its ability to continue as a going concern.

Medicale Corp. reports a reduced net loss for the three and six months ended March 31, 2025, while continuing efforts to raise capital and commence operations.

Medicale Corp. files an amendment to its Q1 2025 10-Q report solely to correct typographical errors, with no material changes to the original filing.

Medicale Corp. reports a decreased net loss for the quarter ended December 31, 2024, while continuing efforts to raise capital and commence operations.

Medicale Corp. reports a net loss of $41,332 for the nine months ended June 30, 2024, as it continues to seek additional funding.

Medicale Corp.'s Q2 2024 filing reveals minimal assets, ongoing losses, and substantial doubt about its ability to continue as a going concern.

Medicale Corp. reports a net loss of $19,307 for the quarter ended December 31, 2023, with concerns raised about the company's ability to continue as a going concern.